Diabetic Patients: Some Benefits from Fibrates

Anthony Keech Diabetic Patients: Some Benefits from Fibrates
Anthony Keech

Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically significant reduction of cardiovascular events, but no reduction in the risk of death. Anthony Keech of University of Sydney told AHA delegates about his findings.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Click here for all the interviews from AHA 2005

This entry was posted in AHA 2005, Cardiovascular and tagged , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>